Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Knop

Showing results (51-60 of 508) with videos related to

Pageof 51
Sort By:
Diabetes, Obesity & Metabolism|September 29, 2011
Current evidence for a role of GLP-1 in Roux-en-Y gastric bypass-induced remission of type 2 diabetesN A Rhee, T Vilsbøll, F K Knop
Drugs of Today (Barcelona, Spain : 1998)|October 3, 2013
Lixisenatide for the treatment of type 2 diabetesA B Petersen, F K Knop, M Christensen
Expert Opinion on Drug Metabolism & Toxicology|October 26, 2012
GLP-1 agonists for type 2 diabetes: pharmacokinetic and toxicological considerationsMaria J Jespersen, Filip K Knop, Mikkel Christensen
Endoscopy|June 25, 2003
Small-bowel hemangiosarcoma and capsule endoscopyF K Knop, M B Hansen, S Meisner
Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy|March 26, 2011
Incretin mimetics: a novel therapeutic option for patients with type 2 diabetes - a reviewKatrine B Hansen, Tina Vilsbøll, Filip K Knop
International Journal of Pharmaceutics|April 19, 2011
Suspension pellet layering using PVA-PEG graft copolymer as a new binderL Suhrenbrock, G Radtke, K Knop, et al.
European Journal of Endocrinology|April 25, 2014
Bile acid sequestrants in type 2 diabetes: potential effects on GLP1 secretionDavid P Sonne, Morten Hansen, Filip K Knop
Current Opinion in Endocrinology, Diabetes, and Obesity|January 23, 2022
Long-acting amylin analogues for the management of obesityDavid S Mathiesen, Jonatan I Bagger, Filip K Knop
Current Diabetes Reports|December 25, 2015
GLP-1 and Amylin in the Treatment of ObesityT Jorsal, J Rungby, F K Knop, et al.
The Journal of Clinical Endocrinology and Metabolism|August 24, 2018
New Avenues in the Regulation of Gallbladder Motility-Implications for the Use of Glucagon-Like Peptide-Derived DrugsIda M Gether, Christina Nexøe-Larsen, Filip K Knop
Pageof 51

Showing results (51-60 of 508) with videos related to

Sort By:
Pageof 51
Diabetes, Obesity & Metabolism|September 29, 2011
Current evidence for a role of GLP-1 in Roux-en-Y gastric bypass-induced remission of type 2 diabetesN A Rhee, T Vilsbøll, F K Knop
Drugs of Today (Barcelona, Spain : 1998)|October 3, 2013
Lixisenatide for the treatment of type 2 diabetesA B Petersen, F K Knop, M Christensen
Expert Opinion on Drug Metabolism & Toxicology|October 26, 2012
GLP-1 agonists for type 2 diabetes: pharmacokinetic and toxicological considerationsMaria J Jespersen, Filip K Knop, Mikkel Christensen
Endoscopy|June 25, 2003
Small-bowel hemangiosarcoma and capsule endoscopyF K Knop, M B Hansen, S Meisner
Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy|March 26, 2011
Incretin mimetics: a novel therapeutic option for patients with type 2 diabetes - a reviewKatrine B Hansen, Tina Vilsbøll, Filip K Knop
International Journal of Pharmaceutics|April 19, 2011
Suspension pellet layering using PVA-PEG graft copolymer as a new binderL Suhrenbrock, G Radtke, K Knop, et al.
European Journal of Endocrinology|April 25, 2014
Bile acid sequestrants in type 2 diabetes: potential effects on GLP1 secretionDavid P Sonne, Morten Hansen, Filip K Knop
Current Opinion in Endocrinology, Diabetes, and Obesity|January 23, 2022
Long-acting amylin analogues for the management of obesityDavid S Mathiesen, Jonatan I Bagger, Filip K Knop
Current Diabetes Reports|December 25, 2015
GLP-1 and Amylin in the Treatment of ObesityT Jorsal, J Rungby, F K Knop, et al.
The Journal of Clinical Endocrinology and Metabolism|August 24, 2018
New Avenues in the Regulation of Gallbladder Motility-Implications for the Use of Glucagon-Like Peptide-Derived DrugsIda M Gether, Christina Nexøe-Larsen, Filip K Knop
Pageof 51